The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical observation in nasopharyngeal carcinoma (NPC) treated with the anti-EGFR monoclonal antibody followed by helical tomotherapy.
L. Feng
No relevant relationships to disclose
H. Jun
No relevant relationships to disclose
B. CAI
No relevant relationships to disclose
N. LU
No relevant relationships to disclose
L. DU
No relevant relationships to disclose
L. MA
No relevant relationships to disclose
S. Xu
No relevant relationships to disclose
X. Zhang
No relevant relationships to disclose
C. Xie
No relevant relationships to disclose